Understanding & Treating Radiation Proctitis Resulting from Prostate Cancer Treatment

One of the more common side effects of primary prostate cancer treatment with any form of x-ray or ionizing radiation is known as radiation proctitis and the related radiation colitis. Radiation proctitis is inflammation and damage to surrounding organs and tissue caused by stray radiation. Radiation proctitis most commonly occurs after treatment for many different [...]

DOD Gets a Thumbs Up From Congress for FY14 – Some Great News

Yesterday we did have some good news for cancer survivors which didn’t get any significant attention. Most of the media attention from yesterday’s congressional budget vote was focused on an amendment dealing with NSA surveillance, the House did actually vote on final passage on the FY14 Defense Appropriations bill which included funding for the Department [...]

Short Video Explaining Xofigo (Radium 223 Dichloride, Alpharadin or Radium 223)

The New England Journal of Medicine just published a very appealing and easy to understand video about Xofigo dichloride (Radium 223 or Alpharadin), the newly FDA approved treatment for men with advanced prostate cancer who have developed bone metastasis. The short video can be viewed at: N.E. Journal Xofigo Video Joel T. Nowak, M.A., M.S.W.

The Positive Effects of Endurance Training for Men with Advanced Prostate Cancer On ADT

All of us on androgen deprivation therapy (ADT) know that without testosterone our bodies change and we will develop insulin resistance, the precursor to diabetes. In a just very small, just published study investigators examined if endurance training would improve insulin sensitivity and body composition in men being treated with ADT for their advanced prostate [...]

Radium-223, An Alpha Emitter Treatment for Advanced Prostate Cancer Called A Breakthrough Treatment

In an interview about radium 223 with Medscape Medical News, Dr. Vapiwala pointed out that radium-223 is the first alpha-emitter to reach the market, and described it as a "breakthrough for radiopharmaceuticals" and "another breakthrough for prostate cancer," as it joins several other agents that have recently been approved for this disease. She characterized the [...]

Testosterone Therapy Produces Mixed Results in Post-Surgical Men with Prostate Cancer

Many men, after they have had a radical prostatectomy, find that their testosterone levels are low and are desirous of supplementing their testosterone. (This low level of testosterone is not a result of the surgery). One way of supplementing androgens is by transdermal testosterone-replacement therapy (TRT), but TRT also has the undesirable effect of increasing [...]

Evidence That Vitamin D3 Levels Effect Survival in Men with Stage IV Advanced Prostate Cancer

Conversations among survivors and evidence in the literature suggests that there is a positive association between serum 25-hydroxyvitamin D [25(OH)D] (vitamin D3) and survival in certain types of cancer, including advanced prostate cancer. Researchers from the Cancer Treatment Centers of America investigated the relationship between survival advantage and vitamin D3 levels in [...]

Efficacy and Safety of Enzalutamide (Xtandi) Monotherapy in Hormone-Naive Prostate Cancer (HNPC)

Xtandi is often referred to as a “super bicalutamide (Casodex).” Casodex functions as a androgen blockade, which deters testosterone from being able to interact with the prostate cancer cell and feed the growth of the cancer. There are some oncologists in the United States and the standard hormone treatment in Europe often utilizes Casodex as [...]

Sorting Out the Recent Negative News about the Role of Omega 3 Fatty Acids in the Diet & Its Relationship to Prostate Cancer

The recent news is unavoidable, Omega-3 Fatty Acids, usually used by men with heart ailments and prostate cancer is tied to a 71% increase of developing prostate cancer and that the cancer is often an aggressive prostate cancer! A prospective study by scientists at Fred Hutchinson Cancer Research Center has confirmed the link between high [...]

Go to Top